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Objective: The St. George’s Respiratory Questionnaire
(SGRQ) has been validated and widely used in assessing
quality of life among patients with chronic obstructive
pulmonary disease (COPD), but it is time-consuming 
and complicated to score. A more concise instrument, the
Airways Questionnaire (AQ), was developed to measure
quality of life (QoL) among patients with asthma and
COPD. The shorter version of this instrument has 20
items (AQ20) and the longer version has 30 items
(AQ30). The purpose of this study was to determine 
the relationship between QoL scores measured by the
AQ20/30 or the SGRQ scale and utilization of health-care
services by COPD patients and to evaluate the compara-
tive advantage of any one of these instruments in mea-
suring the QoL of COPD patients.
Methods: Results from a survey of 1000 patients partic-
ipating in a pilot COPD health management program
were used for this analysis. A total of 303 patients com-
pleted both the AQ20/30 and the SGRQ questionnaires.
Logistic regression models were used to analyze the rela-
tionship between utilization of health care services 
and QoL scores while controlling for a set of covariates.
Spearman’s rank correlation was used to determine
whether the AQ30 and the SGRQ scores for symptoms,
activity, and impact, and the overall scores were 
correlated.
Results: The regression results demonstrate that there 
is a strong relationship between quality-of-life scores and
health-care utilization variables. Moreover, the degree of
association between the AQ20/30 scores and utilization
variables and the SGRQ and utilization variables are
comparable. Both the AQ20 and the AQ30 were highly
correlated with the overall SGRQ score and with symp-
toms, activity, and impact component scores.
Conclusion: The AQ20/30 and the SGRQ scores are com-
parable in terms of measuring QoL in COPD patients and
are equally useful in determining the association between
utilization of health-care services and QoL.
Keywords: quality of life, SGRQ score, AQ20/30 score,
COPD.
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ABSTRACT
Introduction
A number of instruments have been developed 
to measure health-related quality of life (QoL) for
patients with chronic obstructive pulmonary disease
(COPD). The St. George’s Respiratory Question-
naire (SGRQ) is one that has been widely used in
many clinical trials and as a strategy for monitor-
ing the outcomes of clinical interventions [1–3]. The
SGRQ is a 76-item self-administered questionnaire,
which asks patients to review their health status.
The responses for these questions are weighted to
produce three component scores and a total score.
The component scores are:
1. Symptom score—measures distress caused by
respiratory symptoms;
2. Activity score—measures the effect of distur-
bances to physical activities that cause or are
limited by breathlessness;
3. Impact score—measures the impact of social
functioning and psychological disturbances
resulting from the disease.
The SGRQ has been shown to be reproducible
and valid in terms of its ability to detect important
changes over time [4]. However, this instrument
requires considerable time for patients to complete.
The average completion time for the SGRQ is esti-
mated to be about 10 minutes, not including the
time required for scoring [5,6]. To address the
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problem of size and complexity of questionnaires,
Jones et al. and Quirk and Jones [4,7] developed a
simpler instrument called the Airways Question-
naire (AQ). The questionnaire has two versions: the
longer version of this instrument contains 30 items
(AQ30) with yes/no responses. The shorter version
(AQ20) contains 20 of the items present in the
AQ30 and takes about 3 minutes to complete and
score [8]. It has been demonstrated that both the
AQ20 and the AQ30 were as valid and as respon-
sive as the SGRQ in terms of evaluating QoL of
patients with COPD [5] and asthma [8].
Previous studies have hypothesized that poor
QoL scores on the SGRQ scale are associated 
with hospital readmission for COPD and use of
resources such as nebulizers [9]. There is also evi-
dence suggesting that when QoL improves as a
result of some intervention strategies, utilization of
services such as consultations and hospital admis-
sion appears to decrease [10,11]. The purpose of
this study was therefore to substantiate previous
ﬁndings and determine the association between
QoL scores measured by the AQ20/30 or the SGRQ
scale and utilization of health-care services by
COPD patients. This study also evaluated the com-
parative advantage of any one of these instruments
in measuring health-related QoL of COPD patients.
Methods
Data from a survey of patients with COPD partic-
ipating in a pilot health management program
offered by Medco Health were used to evaluate 
the health-related quality of life of participants
using the two different quality-of-life instruments.
Patients were initially identiﬁed for the study if they
were age 45 or older and had received prescriptions
during the prior 6 months for one or more medica-
tions prescribed for COPD (anticholinergics, short-
acting beta-agonists, long-acting beta-agonists,
theophylline, or inhaled corticosteroids).
A random sample of 1000 participants in a
COPD health management program was sent 
a health assessment questionnaire (HAQ) that
included both the AQ20/30 and the SGRQ. A total
of 303 patients completed the AQ20/30, the SGRQ,
or both. Patients were excluded if they stated that
they had asthma but not COPD including chronic
bronchitis and emphysema (62 patients), if they
reported that they had no respiratory problems (35
patients), or if they responded to only one of the
questionnaires (25 patients). The analytical data set
for this study consists of the 181 patients who con-
ﬁrmed their diagnosis as being COPD and who
completed both the AQ30 and the SGRQ. In 
addition, the survey captured information on risk
factors (smoked 100 or more cigarettes over a life-
time), preventive care (inﬂuenza and pneumonia
vaccination), health-care utilization, productivity,
and other demographic factors. Self-reported
health-care utilization related to COPD during the
past 12 months included frequency of hospital
admissions, emergency room (ER) visits, physician
ofﬁce visits, and home care administered by a nurse
or other provider.
Patients in the study sample were stratiﬁed into
three subgroups based on the severity of their 
condition. Severity was deﬁned by the frequency of
claims for respiratory medications and antibiotics
during the 12 months before program enrollment.
Patients with fewer than 6 prescription claims for
respiratory medications and fewer than 4 prescrip-
tion claims for respiratory antibiotics were classi-
ﬁed as low severity. Patients with more than 14
prescriptions for respiratory medications and more
than 7 prescriptions for respiratory antibiotics were
classiﬁed as high severity. Intermediate cases were
classiﬁed as moderate severity. The stratiﬁcation
algorithm was developed for this health manage-
ment program with the input and review of an
external medical advisory board.
The survey did not capture self-reported medica-
tion use or the presence or absence of other comor-
bid conditions. However, prescription drug
utilization history of respondents from our drug
claims database was analyzed and a proxy for
comorbidity based on nonrespiratory drugs ﬁlled
during the past 12 months was created. The pres-
ence of comorbid conditions was determined on the
basis of the previous 12-month drug utilization for
chronic illness using the approach developed by
Clark et al. [12].
Health-related QoL was assessed using the
AQ20, AQ30, and SGRQ scores. The AQ20/30
scores are determined by summing the “yes = 1”
and “no = 0” responses to provide a QoL score out
of a maximum possible total of 20 for the AQ20 or
a maximum possible total of 30 for the AQ30, with
a score of 0 indicating no adverse condition. Each
item in the SGRQ has empirically derived weights
and provides an overall score and three component
scores for symptoms, activity, and impact, each
score ranging from 0 to 100, where 100 indicates
the worst possible health.
Statistical Analysis
Spearman rank-order correlation was used to deter-
mine whether the AQ20/30 and the SGRQ scores
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for symptoms, activity, and impact and the overall
scores were correlated. Logistic regression was used
to describe the relationship between health-care uti-
lization (such as hospital admissions, ER visits,
home-care use, and physician ofﬁce visits) and QoL
scores (SGRQ, AQ30, and AQ20) along with other
covariates. The health-care utilization variables are
dichotomous with a “yes” or “no” response. The
strength of the relationship between utilization and
explanatory variables is assessed using the stan-
dardized parameter estimates of the logistic regres-
sion analysis.
Results
Demographic characteristics, health-care utiliza-
tion, and health-related QoL measures of the study
group are shown in Table 1. The average age of 
participants was 68 years, 54% were female, only
18% were fully employed, and 64% were previous
or current smokers. Eighty percent received an
inﬂuenza vaccination during the previous
12 months, and 73% reported receiving a vaccina-
tion for pneumonia. About 19% of COPD patients
were admitted to a hospital for an average of
7.2 days each during the previous 12 months.
Twenty-ﬁve percent of respondents had visited an
emergency room and 77% had visited the doctor’s
ofﬁce at least once during the past 12 months.
About 8% reported using home-care services during
the same period; the average number of visits was
5.6.
Spearman Rank-Order Correlation
Consistent with the ﬁndings of similar studies [5,8],
the AQ20/30 correlated well with the SGRQ total
and component scores as indicated in Table 2. A
high correlation suggests that there is a high degree
of agreement between the two instruments. The cor-
relations between the AQ20 and the SGRQ scores
and between the AQ30 and the SGRQ scores were
statistically signiﬁcant (P < .01).
Regression Analysis
Logistic regression analyses were used to identify
variables that had a high degree of association with
utilization of health-care services. Three different
Table 1 Health proﬁles of participants in the COPD quality-of-life study
Sample size 181
Demographic characteristics
Average age (mean ± SD) 68 ± 10.4
% Female 54
Health-related QoL sores (mean ± SD)
AQ20 9.9 ± 5.2
AQ30 14.3 ± 7.3
SGRQ
Symptoms 58.3 ± 21.5
Activity 63.6 ± 28.2
Impact 42.9 ± 26.6
Total 50.7 ± 23.1
Preventive care
% Inﬂuenza vaccination (during the previous 12 months) 79.6
% Pneumonia vaccination (during the previous 12 months) 72.9
Medical utilization because of COPD during the previous 12 months
Hospital admissions (% and average length of stay for those with admission) (19.3, 7.2)
ER visit (% and average number of ER visits for those with visits) (25.4, 2.7)
Physician ofﬁce visits (% and average number of visits for those with ofﬁce visits) (76.8, 5.4)
Home care visits (% and average number of visits for those with visits) (7.7, 5.6)
Severity index (respiratory medication use before program enrollment)
% High 6.1
% Moderate 55.2
% Low 38.7
Comorbidity index (nonrespiratory medication use for other chronic illnesses)
Number of comorbid conditions (mean ± SD) 3.3 ± 2.2
Other measures
% Who smoked at least 100 cigarettes over a lifetime 63.6
% Full-time employed 18.2
Abbreviations:AQ,Airways Questionnaire; COPD, chronic obstructive pulmonary disease; QoL, quality of life; SGRQ, St. George’s Respiratory Questionnaire.
Table 2 Correlation between AQ20/AQ30 and SGRQ
AQ30 (N = 181) AQ20 (N = 181)
SGRQ (N = 181)
Symptoms 0.69* 0.67*
Activity 0.70* 0.69*
Impact 0.80* 0.79*
Total score 0.83* 0.82*
*Correlation between the scores was statistically signiﬁcant at the .01 level.
Abbreviations: AQ, Airways Questionnaire; SGRQ, St. George’s Respiratory
Questionnaire.
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models were used for the analyses—one for each of
the three QoL instrument variables (the SGRQ total
score, AQ20 score, and AQ30 score). The three
QoL variables, along with a number of covariates
such as comorbidity and patient severity, patient
age, and whether the patient received a previous
inﬂuenza or pneumonia vaccination, were used as
independent or explanatory variables. Each of the
utilization variables (ER visits, hospital admissions,
ofﬁce visits, and home-care visits) is used as a
dependent or outcome variable. A total of 12 sepa-
rate analyses were performed, 1 for each combina-
tion of the four utilization variables and the three
QoL instruments. The results are summarized in
Table 3.
In almost all the models presented in Table 3, the
three QoL instruments have a much higher degree
of association with utilization of health-care ser-
vices compared to the other explanatory variables.
With the exception of home care visits, health-care
utilization variables are signiﬁcantly related to QoL
measures. For example, in model 1 the AQ20 score
shows a much higher association with the likeli-
hood of ER admission (P < .01), hospital admission
Table 3 Logistic regression models to determine the likelihood of utilization of health-care services by COPD patients: com-
parative analysis of the AQ20/30 and the SGRQ scores
Logistic
ER visits Hospital admission Home-care visits Ofﬁce visits
regression Standardized Standardized Standardized Standardized
models Parameters Estimate estimate Estimate estimate Estimate estimate Estimate estimate
Model 1 Intercept -2.97 — - 5.63† — -12.07† — 1.00 —
AQ20 score 0.15† 0.41 0.13† 0.35 0.12 0.34 0.12† 0.33
Sex (female vs. male) 0.29 — 0.05 — -0.12 — -0.50 —
Comorbidity index 0.03 0.03 0.18 0.21 0.51† 0.61 -0.07 -0.08
(No. of comorbid
conditions)
Severity scale 0.17 0.05 -0.12 -0.04 0.31 0.10 0.06 0.02
(1 = low, 2 = medium,
3 = high)
Age 0.00 0.02 0.04 0.24 0.08* 0.46 0.01 0.07
Inﬂuenza vaccine -0.74 — 0.50 — 0.30 — 0.49 —
(yes vs. no)
Pneumonia vaccine 0.10 — -1.38† — -0.66 — -2.07† —
(yes vs. no)
Model 2 Intercept -2.75 — -5.50† — -11.68† — 1.03 —
AQ30 score 0.09† 0.35 0.08* 0.32 0.06 0.25 0.09† 0.34
Sex (female vs. 0.29 — 0.05 — -0.16 — -0.50 —
male)
Comorbidity index 0.03 0.03 0.18 0.21 0.51† 0.60 -0.07 -0.08
(No. of comorbid
conditions)
Severity scale 0.23 0.07 -0.08 -0.03 0.39 0.12 0.06 0.02
(1 = low, 2 = medium,
3 = high)
Age 0.00 0.02 0.04 0.23 0.08* 0.45 0.01 0.07
Inﬂuenza vaccine -0.73 — 0.51 — 0.33 — 0.45 —
(yes vs. no)
Pneumonia vaccine 0.11 — -1.38† — -0.65 — -2.04† —
(yes vs. no)
Model 3 Intercept -2.21 — -5.00† — -10.84† — 1.47
SGRQ score 0.03† 0.43 0.03† 0.39 0.00 0.04 0.02* 0.26
Sex (female vs. 0.33 — 0.09 — -0.27 — -0.50 —
male)
Comorbidity index -0.02 -0.02 0.14 0.17 0.51† 0.61 -0.08 -0.09
(No. of comorbid
conditions)
Severity scale 0.19 0.06 -0.13 -0.04 0.61 0.19 0.17 0.06
(1 = low, 2 = medium,
3 = high)
Age -0.01 -0.06 0.03 0.17 0.08* 0.42 0.00 0.02
Inﬂuenza vaccine -0.70 — 0.58 — 0.43 — 0.57 —
(yes vs. no)
Pneumonia vaccine 0.08 — -1.41† — -0.65 — -2.07† —
(yes vs. no)
*Statistically signiﬁcant at the .05 level.
†Statistically signiﬁcant at the .01 level.
Abbreviations:AQ,Airways Questionnaire; COPD, chronic obstructive pulmonary disease; SGRQ, St. George’s Respiratory Questionnaire.
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(P < .01), or physician ofﬁce visits (P < .01). Similar
results are found for the other two models (Table
3). However, home-care use does not appear to be
associated with any of the QoL scores. In all three
models, the presence of multiple comorbid condi-
tions (P < .01) and age (P < .05) are indicated to be
the most important determinants of home care use.
Note also that vaccination for pneumonia is nega-
tively associated with hospital admissions (P < .01)
and ofﬁce visits (P < .01).
Judging from the magnitude of the standardized
parameter estimates and the associated P values in
the logistic regression models (Table 3), all three
instruments are comparable in terms of the degree
of association with utilization of services. Com-
pared to the other explanatory variables, the AQ20,
AQ30, and SGRQ scores are much stronger deter-
minants of ER visits, hospital admissions, or ofﬁce
visits.
Discussion
These results suggest that there is a strong relation-
ship between quality-of-life scores and health-care
utilization variables. Poor quality of life as indicated
by high AQ20/30 and SGRQ scores is related to a
greater likelihood of hospitalization, ER visits, and
physician ofﬁce visits. Moreover, these QoL mea-
sures are comparable in determining the likelihood
of use of health-care services by COPD patients.
However, use of home care services does not appear
to be inﬂuenced by any of the QoL scores.
QoL instruments are designed to quantify the
overall beneﬁt of health-care interventions to the
patient. In this regard, reducing the number of ques-
tions in a health-related QoL instrument, without
compromising its validity and its ability to detect
important changes over time, would be a priority.
In almost all the analyses in this study, the AQ20/30
scores are as useful and as sensitive as the SGRQ
score in determining the likelihood of utilization of
health-care services. Previous studies have con-
ﬁrmed that the AQ20 and the AQ30 summary
scores are as valid as the SGRQ scores when mea-
suring QoL in COPD patients [5]. These ﬁndings
lead us to conclude that, because of its simplicity in
answering and scoring in a short period of time and
its high degree of association with health-care uti-
lization variables, the AQ20/AQ30 could be a desir-
able instrument for measuring the overall
health-related QoL of COPD patients.
In evaluating health-related QoL and utilization
of health-care services of COPD patients, the AQ30
has no measurable advantage over the AQ20. In a
previous study using both cross-sectional and lon-
gitudinal data, the AQ20 and AQ30 were found 
to perform similarly to each other in quantifying
health status [8]. In situations where respondents’
time and the length of the questionnaires are sig-
niﬁcant barriers to completion of QoL questions,
the AQ20 could provide a meaningful alternative.
In particular, the AQ20 could be a more efﬁcient
and desirable alternative for collecting health
outcome data for evaluation of programs such as
health and disease management initiatives.
We acknowledge that the ﬁndings of this study
may have been affected by the method of adminis-
tration of the survey or by response bias. The SGRQ
was designed as a supervised self-administered
questionnaire and not a mail survey. It has been
reported that, compared to interviewer-based ques-
tionnaires, self-administered surveys yield a sys-
tematically greater QoL impairment [13]. One
indication of possible bias in the survey is the lower
than expected self-reported rates of lifetime
smoking (64%), considering that tobacco smoking
accounts for 80% to 90% of COPD cases in the
United States [14]. It is possible that COPD patients
without a smoking history were overrepresented
among survey respondents, perhaps due to an
enhanced interest in health information and health-
promoting activities. Alternatively, respondents
may have been reluctant to acknowledge the true
extent of their smoking history in this nonanony-
mous questionnaire. It is also possible that some
respondents actually had asthma (or some other res-
piratory condition) rather than COPD, despite their
self-reported diagnosis.
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